Jason Beckta

Publications

• Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
• What accounts for the suspicious lesion on this first screening mammogram in an HIV-positive woman?
• Autophagy and radiosensitization in cancer
• Capsule Commentary on Patel el al., Using Active Choice Within the Electronic Health Record to Increase Influenza Vaccination Rates
• DNA damage response in human stem cells and neural descendants
• Defining an Intermediate-risk Group for Low-grade Glioma: A national cancer database analysis
• Peptide Library Approach to Uncover Phosphomimetic Inhibitors of the BRCA1 C-Terminal Domain
• Revisiting p53 for cancer-specific chemo- and radiotherapy: Ten years after
• Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer
• Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
• Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control
• Laser interstitial thermal therapy for treatment of cerebral radiation necrosis
• Orally bioavailable and blood–brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice
• Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor
• Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin
• The Higher the Grade, the Bigger the Field
• MRI-Guided Laser Interstitial Thermal Therapy for Radiation Necrosis in Previously Irradiated Brain Arteriovenous Malformations
• Synthesis of water-soluble camptothecin-polyoxetane conjugates via click chemistry
• Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma
• Re: Catherine H. Marshall, Alexandra O. Sokolova, Andrea L. McNatty, et al. Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations. Eur Urol 2019;76:452–8
• Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining [Oncotarget, 6, 29 (2015) (27674-27687)] doi: 10.18632/oncotarget.4876
• Targeting DNA repair in gliomas
• Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
• ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation
• Cutaneous T-cell lymphoma: Trends in radiation doses and patterns of care 2004-2015
• An Evaluation of Health Numeracy among Radiation Therapists and Dosimetrists
• Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists
• Laser Interstitial Thermotherapy for Treatment of Symptomatic Peritumoral Edema After Radiosurgery for Meningioma
• The Use of Low-Dose Radiotherapy in Osteoarthritis: A Review.
• Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'.
• Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity.
• Autophagy and radiosensitization in cancer.
• In Regard to Shah et al.
• 21C Financials - Humana and UHC - from Case No. 2:20-cr-00115-JLB-MRM (M.D. Fla. Feb. 24, 2021)
• 2022 Radiation Oncology qui tam case - Kentucky Supervision Judge Appeal Denial
• Organizations Supporting Permanent Virtual Direct Supervision (PHE Rules)
• Supervision Rules - Executive Summary and Revised List of Support - RadOnc March 2024
• High Yield - Mechanisms of Action in LDRT for Osteoarthritis
• Patent Application Publication - 2014 CM Computer Software
• In Regard to Yu et al